Measurement of myocardial blood flow by radiolabeled tracers.
作者信息
Wilson R A
出版信息
J Nucl Med. 1993 Sep;34(9):1518-9.
PMID:8355073
Abstract
摘要
相似文献
1
Measurement of myocardial blood flow by radiolabeled tracers.用放射性示踪剂测量心肌血流量。
J Nucl Med. 1993 Sep;34(9):1518-9.
2
Thallium-201 and technetium-99m-sestamibi for assessing viable myocardium.铊-201和锝-99m-甲氧基异丁基异腈用于评估存活心肌。
J Nucl Med. 1992 May;33(5):815-8.
3
4
Advances in myocardial perfusion imaging: 99mTc-teboroxime.心肌灌注成像的进展：锝[99mTc]替硼肟
J Nucl Biol Med (1991). 1992 Apr-Jun;36(2 Suppl):22-8.
5
Technetium-labeled myocardial perfusion agents.
Cardiol Clin. 1994 May;12(2):187-98.
6
[Evaluation of myocardial viability by isotopic methods].[用同位素方法评估心肌活力]
Rev Esp Cardiol. 1994;47 Suppl 4:116-23.
7
Experimental studies of the physiologic properties of technetium-99m agents: myocardial transport of perfusion imaging agents.锝-99m 制剂生理特性的实验研究：灌注显像剂的心肌转运
Am J Cardiol. 1990 Oct 16;66(13):9E-15E. doi: 10.1016/0002-9149(90)90606-2.
8
[Thallium-201 and sestamibi: principles and kinetics of the two tracers].
G Ital Cardiol. 1991 Aug;21(8):885-8.
9
Physiological basis of myocardial perfusion imaging with the technetium 99m agents.锝99m制剂心肌灌注显像的生理基础。
Semin Nucl Med. 1991 Jul;21(3):173-81. doi: 10.1016/s0001-2998(05)80038-8.
10
Different tracers and stressors in patients with coronary artery disease: how to standardize clinical questions and nuclear cardiology answers.冠心病患者中不同的示踪剂和应激源：如何规范临床问题与核心脏病学的答案。
J Nucl Biol Med (1991). 1994 Dec;38(4):566-72.
引用本文的文献
1
Technetium 99m-labeled teboroxime: death in utero, infanticide, or failure to thrive?
J Nucl Cardiol. 1995 Jan-Feb;2(1):88-91. doi: 10.1016/s1071-3581(05)80016-9.
Zotero 插件